• 1
    Wolff HG. Headache and Other Head Pain. New York: Oxford University Press; 1963:1-688.
  • 2
    Leao A. Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:391-396.
  • 3
    Leao A. Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol. 1947;10:409-414.
  • 4
    Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359-390.
  • 5
    Sanchez del Rio MRU, Moskowitz MA. Central and peripheral mechanisms of migraine. Funct Neurol. 2000;15(Suppl. 3):157-162.
  • 6
    Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64:S9-S15.
  • 7
    Lodi RI, Lotti S, Cortelli P, et al. Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Research Bulletin. 2001;54:437-441.
  • 8
    Ramadan N, Halvorson H, Vande-Linde A, et al. Low brain magnesium in migraine. Headache. 1989;29:590-593.
  • 9
    Sarchielli P, Coata CG, Firenze C, et al. Serum and salivary magnesium levels in migraine and tension-type headache. Cephalalgia. 1992;12:21-27.
  • 10
    Welch KM, Barkley GL, Ramadan NM, D'Andrea G. NMR spectroscopic and magnetoencephalographic studies in migraine with aura: Support for spreading depression hypothesis. Pathol Biol. 1992;40:349-354.
  • 11
    Welch KM, Barkley GL, Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. Neurology. 1993;43(6 Suppl. 3):S21-S25.
  • 12
    Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia. 1991;21:630-636.
  • 13
    Kitano A, Shimomura T, Takeshima T, Takahashi K. Increased 11-dehydrothromboxane B2 in migraine: Platelet hyperfunction in patients with migraine during headache-free preiod. Headache. 1994;34:515-518.
  • 14
    Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, et al. Oxidative stress and platelet responsiveness in migraine. Cephalalgia. 1997;17:580-584.
  • 15
    Bresolin N, Martinelli P, Barbiroli B, et al. Muscle mitochondrial-DNA deletion and P-31-NMR Spectroscopy alterations in a migraine patient. J Neurol Sci. 1991;104:182-189.
  • 16
    Montagna P, Gallassi R, Medori R, et al. MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission. Neurology. 1988;38:751-754.
  • 17
    Montagna P, Sacquegna T, Martinelli P, et al. Mitochondrial abnormalities in migraine. Preliminary findings. Headache. 1988;28:477-480.
  • 18
    Montagna P, Sacquegna T, Cortelli P, Lugaresi E. Migraine as a defect of brain oxidative metabolism: A hypothesis. J Neurol. 1989;236:124-125.
  • 19
    Mazziotta JC, Gilman S. Clinical Brain Imaging: Principles and Applications. Philadelphia, PA: FA Davis Company; 1992:71.
  • 20
    Duncan J. Imaging and epilepsy. Brain. 1997;120:339-377.
  • 21
    Benson DF, Kuhl DE, Hawkins RA, et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol. 1983;40:711-714.
  • 22
    Silverman D. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: Comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med. 2004;45:594-607.
  • 23
    Van Heertum RL, Greenstein EA, Tikofsky RS. 2-deoxy-flluorglucose positron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias. Semin Nucl Med. 2004;34:300-312.
  • 24
    Broich K, Alavi A, Kushner M. Positron emission tomography in cerebrovascular disorders. Semin Nucl Med. 1992;22:224-232.
  • 25
    Di Chiro G. Positron emission tomography using (18F) Fluoro-deoxy-glucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol. 1987;22:360-371.
  • 26
    Glantz MJ, Hoffman JM, Coleman RE, et al. Identification of early recurrence of primary central nervous systemt tumors by (18F) fluorodeoxyglucose positron emission tomography. Ann Neurol. 1991;29:347-355.
  • 27
    Engel JJ. The use of positron emission tomographic scanning in epilepsy. Ann Neurol. 1984;15(Suppl.): S180-S191.
  • 28
    Leiderman DB, Albert P, Balish M, Bromfield E, Theodore WH. The dynamics of metabolic change following seizures as measured by positron emission tomography with fluorodeoxyglucose F18. Arch Neurol. 1994;51:932-936.
  • 29
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders. Cranial neuralgias and facial pain. Cephalalgia. 1998;8(Suppl. 7):1-96.
  • 30
    Headache Classification. Committee of the International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia. 2004;24(Suppl. 1):1-160.
  • 31
    StatView [computer program]. Version 5.0.1. Cary, NC: SAS Institute Inc.; 1998.
  • 32
    Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC. Human Brain Function. New York: Academic Press; 1997:275-299.
  • 33
    Brinciotti M, Guidetti V, Matricardi M, Costesi F. Responsiveness of the visual system in childhood migraine studied by means of VEPs. Cephalalgia. 1986;6:183-185.
  • 34
    Diener HC, Ndosi NK, Koletzki E, Langohr HD. Visual evoked potentials in migraine. In: PfaffenrathV, LundbergPJ, SjasstadO, eds. Updating Headache. Berlin, Springer Verlag; 1984:101-106.
  • 35
    Diener HC, Scholz E, Dichgans J, et al. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potential. Ann Neurol. 1989;25:125-130.
  • 36
    Gawel M, Connolly JF Rose FC. Migraine patients exhibit abnormalities in the visual evoked potential. Headache. 1983;23:49-52.
  • 37
    Kennard C, Gawel M, Rudolph Nde M, Rose FC. Visual evoked potentials in migraine subjects. Headache. 1978;6:73-80.
  • 38
    Winter AL, Cooper L. Neurophysiological measures of the visual system in classic migraine. In: RoseCF, ed. Proceedings of the 5th International Migraine Symposium. Basel: Karger; 1985:2511-2516.
  • 39
    Wray SH, Kosslyn SM. Visual processing in migraineurs. Brain. 1995;118:25-35.
  • 40
    De Renzi E, Colombo A, Faglioni P, Gibertoni M. Conjugate gaze paresis in stroke patients with unilateral damage. An unexpected instance of hemispheric asymmetry. Arch Neurol. 1982;39:482-486.
  • 41
    Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: Case-control study. The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999;318:13-18.
  • 42
    Kruit MC, Van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427-434.
  • 43
    Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol. 1997;54:362-368.
  • 44
    Milhaud D, Bogousslavsky J, Van Melle G, Liot P. Ischemic stroke and active migraine. Neurology. 2001;57:1805-1811.
  • 45
    Tzourio C, Iglesias S, Hubert JB, et al. Migraine and risk of ischemic stroke: A case-control study. BMJ. 1993;307:289-292.
  • 46
    Tzourio CS, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischemic stroke in young women. BMJ. 1995;310:830-833.
  • 47
    Andermann F, Lugaresi E, Dvorkin GS, Montagna P. Malignant migraine: The syndrome of prolonged classical migraine. Epilepsia partialis continua, and repeated strokes; a clinically characteristic disorder probably due to mitochondrial encephalopathy. Funct Neurol. 1986;1:481-486.
  • 48
    Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: An original case and clinical criteria for diagnosis. Neuromuscul Disord. 1992;2:125-135.
  • 49
    Couch JR, Bearss C, Verhulst S. Importance of maternal hereditary in the etiology of migraine. Neurology. 1986;36(Suppl. 1):99.
  • 50
    Klopstock T, May A, Seibel P, et al. Mitochondrial DNA in migraine with aura. Neurology. 1996;46:1735-1738.
  • 51
    Russell MB, Hilden J, Sørensen SA, Olesen J. Familial occurrence of migraine without aura and migraine with aura. Neurology. 1993;43:1369-1373.
  • 52
    Biary N, Koller W, Langenberg P. Correlation between essential tremor and migraine headache. J Neurol Neurosurg Psychiatr. 1990;53:1060-1062.
  • 53
    Andreason PJ, Zametkin AJ, Guo AC, et al. Gender-related differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Res. 1994;51:175-183.
  • 54
    Gur RC, Mozley LH, Mozley PD, et al. Sex differences in regional cerebral glucose metabolism during a resting state. Science. 1995;267:528-531.